v3.26.1
FINANCIAL INSTRUMENTS (Tables)
12 Months Ended
Mar. 31, 2026
Investments, All Other Investments [Abstract]  
SCHEDULE OF FINANCIAL INSTRUMENTS

 

   As of
January 4, 2023
 
     
Derivative liabilities – Fair value of the Warrants  $3,858,521 
Derivative liabilities – Embedded conversion feature   1,247,500 
Convertible Note   9,893,979 
   $15,000,000 
SCHEDULE OF CONVERTIBLE NOTES OBLIGATION

The movement of the Company’s convertible notes obligations were as the following for the year ended March 31, 2026 and 2025:

 

   2026   2025 
   Year ended March 31, 
   2026   2025 
Carrying value – beginning balance  $2,900,160   $2,684,697 
Converted to Common Stock   (3,054,240)   (82,642)
Redemption   (400,756)   (544,706)
Amortization of debt discount   484,732    823,058 
Deferred debt discount and cost of issuance   -    (250,061)
Interest charge   70,104    269,814 
Carrying value – ending balance  $Nil   $2,900,160 
SCHEDULE OF DERIVATIVE LIABILITIES

The Company’s derivative liabilities were as the following for the year ended March 31, 2026 and 2025:

 

   2026   2025 
   Year ended March 31, 
   2026   2025 
Derivative liabilities –Warrants  $    $  
Beginning balance   989,852    251,657 
Marked to the market   3,511,210    738,195 
Ending fair value   4,501,062    989,852 
           
Derivative liabilities – Embedded conversion feature          
Beginning balance   1,782,498    36,298 
Converted to Common Stock   (1,589,352)   (1,330)
Remeasurement on change of convertible price   17,625    248,217 
Redemption   (8,979)   (103,786)
Marked to the market   (201,792)   1,603,098 
Ending fair value   Nil    1,782,498 
           
Total Derivative fair value at end of period  $4,501,062   $2,772,350